Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Patricia LoRusso
Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered With PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology
Anti-Pd-1 Monoclonal Antibody MEDI0680 in a Phase I Study of Patients With Advanced Solid Malignancies
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Safety and Pharmacokinetics of MM-302, a HER2-targeted Antibody–liposomal Doxorubicin Conjugate, in Patients With Advanced HER2-positive Breast Cancer: A Phase 1 Dose-Escalation Study
British Journal of Cancer
Cancer Research
Oncology
ASP9853, an Inhibitor of Inducible Nitric Oxide Synthase Dimerization, in Combination With Docetaxel: Preclinical Investigation and a Phase I Study in Advanced Solid Tumors
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Results of a Phase I, Open-Label, Randomized, Crossover Study Evaluating the Effects of Linifanib on QTc Intervals in Patients With Solid Tumors
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Physicians’ Use of Patients’ Daily Reports of Quality of Life to Evaluate Treatment Response in Phase I Cancer Trials
Journal of Cancer Therapy
Reversion and Non-Reversion Mechanisms of Resistance to PARP Inhibitor or Platinum Chemotherapy in BRCA1/2-mutant Metastatic Breast Cancer
Phase II Trial of Fenretinide in Advanced Renal Carcinoma
Investigational New Drugs
Oncology
Pharmacology
